Subsequent anti-myeloma therapy after maturation antigen (BCMA) chimeric antigen receptor (CAR)-T cell (HDS269B) treatment in patients with relapsed/refractory multiple myeloma

Chen, DJ; Wang, XX; Chen, Z; Jiang, SF; Jiang, H; Fu, WJ; Xiang, F; Sun, XD; Du, J

Du, J (通讯作者),Naval Med Univ, Shanghai Changzheng Hosp, Dept Hematol, Myeloma & Lymphoma Ctr, 415 Fengyang Rd,Huangpu Area, Shanghai 200003, Peoples R China.

AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (12): E478